In another example, treatment with AMD3100, a selective CXCR4 antagonist, resulted in increased tumor cell apoptosis and necrosis, and selective reduction of foxp3+ regulatory T cells and inducing an immunosuppressive microenvironment [36]. Here, CXCR4 is linked to neoplasm.